Cancers, Free Full-Text

After forty years of essentially unchanged treatment in acute myeloid leukemia (AML), innovation over the past five years has been rapid, with nine drug approvals from 2016 to 2021. Increased understanding of the molecular changes and genetic ontology of disease have led to targeting mutations in isocitrate dehydrogenase, FMS-like tyrosine kinase 3 (FLT3), B-cell lymphoma 2 and hedgehog pathways. Yet outcomes remain variable; especially in defined molecular and genetic subgroups such as NPM1 (Nucleophosmin 1) mutations, 11q23/KMT2A rearranged and TP53 mutations. Emerging therapies seek to address these unmet needs, and all three of these subgroups have promising new therapeutic approaches. Here, we will discuss the normal biological roles of menin in acute leukemia, notably in KMT2A translocations and NPM1 mutation, as well as current drug development. We will also explore how CD47 inhibition may move immunotherapy into front-line settings and unlock new treatment strategies in TP53 mutated disease. We will then consider how these new therapeutic advances may change the management of AML overall.

Particle Illusion 3.02 Download - Colaboratory

I Am Cancer Free! - Cancer Free Gift - Tapestry

Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids

Journal of Cancer Research and Clinical Oncology

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

Hallmarks of Cancer: The Next Generation: Cell

Cancers, Free Full-Text

Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease - eBioMedicine

Cancers, Free Full-Text

Destination Healthy Skin Toolkit - The Skin Cancer Foundation

Cd4 The Sims 2 Get File - Colaboratory

Clinical practice guidelines for management of biliary tract cancers: the 2nd English edition 2015｜Japanese Society of Hepato-Biliary-Pancreatic Surgery

Know the signs of cancer to catch it early

Game Rong Den 5 Get File - Colaboratory

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer